No Data
Form 144 | Vertex Pharmaceuticals(VRTX.US) Officer Proposes to Sell 7.83 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 8, $Vertex Pharmaceuticals(VRTX.US)$ Officer Kewalramani Reshma intends to sell 15,198 shares of its common stock on Nov 8, with a total market value of approximately $7.83
Vertex Pharmaceuticals Faces Integration Challenges in Alpine Acquisition
Argus Raises Price Target on Vertex Pharmaceuticals to $550 From $530
Vertex Pharmaceuticals Price Target Raised to $408.00/Share From $361.00 by Canaccord Genuity
J.P. Morgan Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Announces Target Price $503
CCORF Maintains Vertex Pharmaceuticals(VRTX.US) With Sell Rating, Raises Target Price to $408